Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomizo Nishiguchi is active.

Publication


Featured researches published by Tomizo Nishiguchi.


FEBS Letters | 1998

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

Kerstin Fischer; Verena Lutz; Olaf Wilhelm; Manfred Schmitt; H. Graeff; Peter Heiss; Tomizo Nishiguchi; Nadia Harbeck; Horst Kessler; Thomas Luther; Viktor Magdolen; Ute Reuning

Ovarian cancer metastasis is associated with an increase in the urokinase‐type plasminogen activator (uPA) and its receptor uPAR. We present evidence that binding of uPA to uPAR provokes a mitogenic response in the human ovarian cancer cell line OV‐MZ‐6 in which endogenous uPA production had been significantly reduced by stable uPA ‘antisense’ transfection. High molecular weight (HMW) uPA, independent of its enzymatic activity, produced an up to 95% increase in cell number concomitant with 2‐fold elevated [3H]thymidine incorporation as did the catalytically inactive but uPAR binding amino‐terminal fragment of uPA, ATF. uPA‐induced cell proliferation was significantly decreased by blocking uPA/uPAR interaction by the monoclonal antibody IIIF10 and by soluble uPAR. The efficiency of the uPAR binding synthetic peptide cyclo19,31uPA19–31 to enhance OV‐MZ‐6 cell growth proved this molecular domain to be the minimal structural determinant for uPA mitogenic activity. Dependence of uPA‐provoked cell proliferation on uPAR was further demonstrated in Raji cells which do not express uPAR and were thus not induced by uPA. However, upon transfection with full‐length uPAR, Raji cells acquired a significant growth response to HMW uPA and ATF.


Peptides | 1999

Urocortin in human placenta and maternal plasma

Fumie Watanabe; Yutaka Oki; Megumi Ozawa; Masahiro Masuzawa; Masayasu Iwabuchi; Teruya Yoshimi; Tomizo Nishiguchi; Kazumi Iino; Hironobu Sasano

Plasma immunoreactive (IR-) urocortin (Ucn) and corticotropin-releasing factor (CRF) levels in pregnant women were measured by their specific radioimmunoassays after extraction. Although plasma IR-CRF levels were increased in pregnant women as compared to men and non-pregnant women, there was no difference of plasma IR-Ucn levels among groups. Ucn mRNA was detected in cytotrophoblasts and syncytiotrophoblasts by in situ hybridization. A reverse-phase high-performance liquid chromatography (HPLC) showed the major peak of IR-Ucn in placenta and plasma that had similar chromatographic mobility to synthetic Ucn1-40. These data suggest that Ucn is produced and processed into the same form of synthetic Ucn in placenta, but not secreted into maternal blood.


Journal of Computer Assisted Tomography | 1996

Case report. Antenatal diagnosis of chorioangioma of the placenta: MR features.

Takao Mochizuki; Tomizo Nishiguchi; Ichiro Ito; Michiko Imai; Haruo Isoda; Takayuki Masui; Motoichiro Takahashi; Masao Kaneko; Toshihiko Terao; Yoshihiro Tsutsui

We report a case of chorioangioma of the placenta, in which MR findings were useful in establishing the antenatal diagnosis. Polyhydramnios and a placental tumor that was 5 cm in size were visualized. The tumor had relatively high signal intensities on proton density imaging and T2-weighted imaging and showed partially high intensity signal rims on T1-weighted imaging, especially when using a breath-holding technique. Magnetic resonance imaging has an important role in detection and diagnosis of these lesions, particularly the larger tumors, so that appropriate steps can be taken to deal with the complications that may accompany this tumor.


Pediatrics International | 2011

Vitamin K prophylaxis and late vitamin K deficiency bleeding in infants: Fifth nationwide survey in Japan

Daijiro Takahashi; Akira Shirahata; Susumu Itoh; Yukihiro Takahashi; Tomizo Nishiguchi; Yoshio Matsuda

Background:  In 1980, the first nationwide survey on late vitamin K deficiency bleeding (VKDB) in infants was conducted in Japan, and it was followed by the second, third and fourth nationwide surveys in 1985, 1988 and 1991, respectively. The fifth nationwide survey was designed to ascertain the epidemiology of late VKDB between January 1999 and December 2004.


British Journal of Obstetrics and Gynaecology | 1996

Vitamin K prophylaxis to prevent neonatal vitamin K deficient intracranial haemorrhage in Shizuoka prefecture

Tomizo Nishiguchi; Kozue Saga; Kazuhiro Sumimoto; Kazuchika Okada; Toshihiko Terao

Objective To compare three methods of vitamin K prophylaxis for neonatal vitamin K deficient intracranial haemorrhage.


Current Drug Targets | 2005

Antiphospholipid syndrome: characteristics and obstetrical management.

Tomizo Nishiguchi; Takao Kobayashi

Antiphospholipid syndrome (APS) is characterized by a combination of clinical features consisted of thrombotic or pregnancy-related events and autoimmune antiphospholipid antibodies. In the 1998 International Consensus Preliminary Criteria, APS is defined by the concomitant presence of these clinical features and laboratory tests, including solid immunoassay and lupus anticoagulant (LAC). Current concept of antiphospholipid antibodies directed against plasma proteins with affinity for negatively charged phospholipids, mainly beta2-glyoprotein 1 (beta2GP1) and prothrombin, that is, anti-beta2GP1 and anti-prothrombin antibodies have been shown as a key antibody in the APS, while the pathophysiological mechanisms remain still uncertain. In the recent investigations potential mechanisms, such as endothelial activation induced by bivalent-formed antiphospholipid antibodies and complement activation, have emerged. Recurrent pregnancy losses or fetal death, and increased rates of preeclampsia and placental insufficiency are the clinical features in the APS. It is now accepted that unfractionated or low-molecular-weight heparin in combination with low-dose aspirin represents the current standard treatment for pregnant women with anti-phospholipid antibodies, and high-dose immunoglobulin is considered as a salvage therapy for refractory APS. This review highlights the characteristics of APS and the recent consensus for obstetrical managements in APS.


Congenital Anomalies | 2000

Acrania : an autopsy case and review of the literature

Yuichiro Shinmura; Yoshihiro Tsutsui; Tomizo Nishiguchi; Takao Kobayashi

ABSTRACT We report an autopsy case of acrania with a review of the literature. A 31‐year‐old woman was admitted in poor genaral condition and diagnosed as pregnant at the 26th week of gestation. The fetus was suspected to be anencephalic or hydrocephalic by ultrasonography. She delivered a stillbirth male baby at the 28th week of gestation. Autopsy showed the cranium lacked the cranial vault The scalp directly covered the hydrocephalic brain without calvaria. No cerebellum was found macroscopically. On histological examination, the thinned cerebral layer was composed of white matter‐like brain tissue with glial and ependymal cells. In the cerebral layer near the base of the skull, a few NSE‐positive neurons among many GFAP‐positive glial cells and oligodendrocyte‐like cells were observed. The choroid plexuses were observed inside the ependymal layers. The brain stem and the spinal cord were normally preserved with clusters of NSE‐positive neurons. Agnethia and horseshoe kidney were combined as malformations other than the brain. We reviewed 42 cases of acrania from the literature.


Nucleic Acids Research | 1995

Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1

Ute Reuning; Olaf Wilhelm; Tomizo Nishiguchi; Luisa Guerrini; Francesco Blasi; H. Graeff; Manfred Schmitt


Seminars in Thrombosis and Hemostasis | 1999

Coagulation/fibrinolysis disorder in patients with severe preeclampsia

Takao Kobayashi; Naoki Tokunaga; Kazunao Suzuki; Naohiro Kanayama; Tomizo Nishiguchi; Toshihiko Terao


FEBS Journal | 1999

Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells

Ute Reuning; Luisa Guerrini; Tomizo Nishiguchi; Sharon Page; Hildegard Seibold; Viktor Magdolen; H. Graeff; Manfred Schmitt

Collaboration


Dive into the Tomizo Nishiguchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge